June 20, 2021

Norobotsverification

Latest online bangla news | bd, world, Sports, photo, video live | Norobotsverification

Serum was allowed to produce Sputnik-V

The Russian-made coronavirus vaccine Sputnik-V has received initial permission to be produced locally by the Seram Institute of India. On Friday, the country’s drug regulator, the Drug Controller General of India (DCGI), granted the permission following a request from Serum. As a result, Sputnik-V vaccine can be produced at Seram’s factory in Pune. News from NDTV.

A spokesman for Serum told NDTV: “We (Serum) have received initial approval for the production of the Russian corona vaccine Sputnik-V. However, it may take a few more months to go into full production. The production of two vaccines, Kovishield and Kovaxin, will be in the spotlight.

The European Union and US health authorities have already approved the coronary vaccine Sputnik-Veer. More than 75 countries have approved the use of the vaccine. The first Sputnik-VR was launched in India on May 14 in Hyderabad. Dr. Reddy’s Laboratories is marketing the vaccine in India. At present, the price of Sputnik-V vaccine imported in the Indian market is Rs. 995.40 per dose. Now Dr. wants to start using one dose of Sputnik-V light ticker in India. Reddy’s.

With approval, Sputnik-V will be the third corona vaccine produced at the Seram Institute in Pune. Earlier, the company was producing Oxford-AstraZeneca vaccine Covishield and local company Bharat Biotech’s vaccine Covacin. The two-dose Sputnik-V corona is said to be able to provide 91.8% protection against the disease.

The Russian-made coronavirus vaccine Sputnik-V has received initial permission to be produced locally by the Seram Institute of India. On Friday, the country’s drug regulator, the Drug Controller General of India (DCGI), granted the permission following a request from Serum. As a result, Sputnik-V vaccine can be produced at Seram’s factory in Pune. News from NDTV.

A spokesman for Serum told NDTV: “We (Serum) have received initial approval for the production of the Russian corona vaccine Sputnik-V. However, it may take a few more months to go into full production. The production of two vaccines, Kovishield and Kovaxin, will be in the spotlight.

The European Union and US health authorities have already approved the coronary vaccine Sputnik-Veer. More than 75 countries have approved the use of the vaccine. The first Sputnik-VR was launched in India on May 14 in Hyderabad. Dr. Reddy’s Laboratories is marketing the vaccine in India. At present, the price of Sputnik-V vaccine imported in the Indian market is Rs. 995.40 per dose. Now Dr. wants to start using one dose of Sputnik-V light ticker in India. Reddy’s.

With approval, Sputnik-V will be the third corona vaccine produced at the Seram Institute in Pune. Earlier, the company was producing Oxford-AstraZeneca vaccine Covishield and local company Bharat Biotech’s vaccine Covacin. The two-dose Sputnik-V corona is said to be able to provide 91.8% protection against the disease.